Theme：The Front Line of Innovation in Cancer Research and Therapy
Opening Remarks
 |
Osamu Nagayama
(Tokyo Biochemical Research Foundation) |
Opening Comment
 |
- Speaker:
- Bruce A. Chabner
- (Harvard Medical School, USA)
- Chair/Moderator:
- Yasuo Ikeda
- (Waseda University, Japan)
|
 |
Breakthroughs in Cancer Immunology and Immunotherapy
 |
- Speaker:
- Antoni Ribas
- (University of California, Los Angeles, USA)
- Chair/Moderator:
- Yusuke Nakamura
- (Japanese Foundation for Cancer Research, Japan)
|
 |
 |
- Speaker:
- Shimon Sakaguchi
- (Immunology Frontier Research Center, Osaka Univ., Japan)
- Chair/Moderator:
- Ryuzo Ueda
- (Aichi Medical University, Japan)
|
 |
 |
- Speaker:
- Laurence Zitvogel
- (Gustave Roussy, France)
- Chair/Moderator:
- Noboru Yamamoto
- (National Cancer Center Hospital, Japan)
|
 |
 |
- Speaker:
- Shin Kaneko
- (Center for iPS Cell Research and Application, Kyoto University, Japan)
- Chair/Moderator:
- Mitsuaki Yoshida
- (Japanese Foundation for Cancer Research, Japan)
|
 |
Novel Targets for Cancer Drug Development
 |
- Speaker:
- Bruce E. Johnson
- (Dana-Farber Cancer Institute, USA)
- Chair/Moderator:
- Makoto Ogawa
- (Aichi Cancer Center, Japan)
|
 |
 |
- Speaker:
- Erik Sahai
- (Francis Crick Institute, UK)
- Chair/Moderator:
- Kohei Miyazono
- (The University of Tokyo, Japan)
|
 |
Cancer Genomics and Precision Oncology
 |
- Speaker:
- Elaine R. Mardis
- (Nationwide Children’s Hospital, USA)
- Chair/Moderator:
- Hiroyuki Mano
- (National Cancer Center Research Institute, Japan)
|
 |
 |
- Speaker:
- James M. Ford
- (Stanford University School of Medicine, USA)
- Chair/Moderator:
- Hiroyuki Aburatani
- (The University of Tokyo, Japan)
|
 |
Translational Research in Precision Oncology
 |
- Speaker:
- Josep Tabernero
- (Vall d’Hebron University Hospital, Spain)
- Chair/Moderator:
- Tomomitsu Hotta
- (National Cancer Center, Japan)
|
 |
 |
- Speaker:
- David Hyman
- (Memorial Sloan Kettering Cancer Center, USA)
- Chair/Moderator:
- Hironobu Minami
- (Kobe University, Japan)
|
 |
Targeting Mutant RAS
 |
- Speaker:
- Neal Rosen
- (Memorial Sloan Kettering Cancer Center, USA)
- Chair/Moderator:
- Chikashi Ishioka
- (Tohoku University, Japan)
|
 |
 |
- Speaker:
- Kevan M. Shokat
- (University of California, San Francisco, USA)
- Chair/Moderator:
- Kiyohiko Hatake
- (International University of Health and Welfare, Japan)
|
 |
 |
- Speaker:
- Benjamin G. Neel
- (NYU Langone Health, USA)
- Chair/Moderator:
- Masakazu Toi
- (Kyoto University, Japan)
|
 |
Closing Remarks
 |
Neal Rosen
(Memorial Sloan Kettering Cancer Center, USA) |
